AJP - Endo Fuel your research with LabChart
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH
 QUICK SEARCH:   [advanced]


     


Am J Physiol Endocrinol Metab (November 22, 2006). doi:10.1152/ajpendo.00569.2006
This Article
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
292/3/E884    most recent
00569.2006v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Robinson, K. A.
Right arrow Articles by Buse, M. G.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Robinson, K. A.
Right arrow Articles by Buse, M. G.
Submitted on October 20, 2006
Accepted on November 16, 2006

Reduction of O-GlcNAc protein modification does not prevent insulin resistance in 3T3-L1 adipocytes

Katherine A. Robinson1, Lauren E. Ball1, and Maria G. Buse2*

1 Medicine/Endocrinology, Medical University of South Carolina, Charleston, South Carolina, United States
2 Div. of Endocrinology, Dept. of Medicine, Medical University of South Carolina, Charleston,, South Carolina, United States

* To whom correspondence should be addressed. E-mail: busemg{at}musc.edu.

3T3-L1 adipocytes develop insulin resistant glucose transport upon preincubation with high (25 mM) glucose, provided insulin (0.6 nM) is included; Akt activation is impaired; high glucose and insulin act synergistically. Considerable evidence suggests that increased glucose flux via the hexosamine biosynthesis pathway enhances the O-GlcNAc modification (O-GlcNAcylation) of some critical protein(s), which may contribute to insulin resistance. However, whether enhanced protein O-GlcNAcylation is necessary for the development of insulin resistance is unknown. We used two strategies to test this hypothesis: 1. Overexpression of O-GlcNAcase which removes O-GlcNAc from Ser/Thr of proteins. Cells were infected with O-GlcNAcase expressing adenovirus (or empty virus) 5 days before submitting them to protocols, which elicit (or not) insulin resistance. O-GlcNAcase was highly expressed and functional as assessed by Western blot, O-GlcNAcase assay and by marked reduction of O-GlcNAcylated proteins. The activity was mainly cytosolic. 2. The expression of O-GlcNAc transferase (OGT) was markedly reduced by transfection of OGT siRNA, resulting in ~90% decrease of nuclear and cytosolic OGT protein expression and similar reduction in O-GlcNAcylated proteins. Non-targeting siRNA had no effect. Preincubation in high glucose with low dose insulin decreased the acute insulin response of glucose transport by at least 50% and impaired Akt activation. None of these parameters were affected by overexpression of O-GlcNAcase or by OGT knockout. Excess O-GlcNAcylation is one of many factors that can cause insulin resistance. It does not seem to be required for the development of glucose/insulin induced insulin resistance of glucose transport and Akt activation in 3T3-L1 adipocytes.




This article has been cited by other articles:


Home page
J. Pharmacol. Exp. Ther.Home page
G. A. Ngoh and S. P. Jones
New Insights into Metabolic Signaling and Cell Survival: The Role of {beta}-O-Linkage of N-Acetylglucosamine
J. Pharmacol. Exp. Ther., December 1, 2008; 327(3): 602 - 609.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Endocrinol. Metab.Home page
R. J. Copeland, J. W. Bullen, and G. W. Hart
Cross-talk between GlcNAcylation and phosphorylation: roles in insulin resistance and glucose toxicity
Am J Physiol Endocrinol Metab, July 1, 2008; 295(1): E17 - E28.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Endocrinol. Metab.Home page
K. A. Robinson and M. G. Buse
Mechanisms of high-glucose/insulin-mediated desensitization of acute insulin-stimulated glucose transport and Akt activation
Am J Physiol Endocrinol Metab, May 1, 2008; 294(5): E870 - E881.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH
Visit Other APS Journals Online
Copyright © 2006 by the American Physiological Society.